{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:25:28Z","timestamp":1790673928505,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.seizure.2015.07.007","type":"journal-article","created":{"date-parts":[[2015,7,20]],"date-time":"2015-07-20T13:23:04Z","timestamp":1437398584000},"page":"108-111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Repackaged sodium valproate tablets \u2013 Meeting quality and adherence to ensure seizure control"],"prefix":"10.1016","volume":"31","author":[{"given":"Nichola","family":"Redmayne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherryl","family":"Robertson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jutta","family":"Kockler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Llewelyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Haywood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beverley","family":"Glass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.seizure.2015.07.007_bib0175","series-title":"Australian Medicines Handbook Online","author":"AMH","year":"2015"},{"key":"10.1016\/j.seizure.2015.07.007_bib0180","series-title":"Australian Pharmaceutical Healthcare Systems","author":"APHS","year":"2015"},{"key":"10.1016\/j.seizure.2015.07.007_bib0185","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/j.2055-2335.2007.tb00738.x","article-title":"Stability of frusemide tablets repackaged in dose administration aids","volume":"37","author":"Bowen","year":"2007","journal-title":"J Pharm Pract Res"},{"key":"10.1016\/j.seizure.2015.07.007_bib0190","series-title":"British Pharmacopoeia Online. Volume III. Formulated preparations: specific monographs. Sodium valproate tablets","author":"British Pharmacopoeia","year":"2014"},{"key":"10.1016\/j.seizure.2015.07.007_bib0195","series-title":"British Pharmacopoeia Online. Volume V. Appendix XII B, XII C, XVII G and XVII H","author":"British Pharmacopoeia","year":"2014"},{"key":"10.1016\/j.seizure.2015.07.007_bib0200","first-page":"75","article-title":"How stable are medicines moved from original packs into compliance aids?","volume":"276","author":"Church","year":"2006","journal-title":"Pharm J"},{"key":"10.1016\/j.seizure.2015.07.007_bib0205","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S1525-5050(02)00037-9","article-title":"The relationship between poor medication compliance and seizures","volume":"3","author":"Cramer","year":"2002","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2015.07.007_bib0210","series-title":"EasyBLIST\u00ae","author":"EasyBLIST","year":"2015"},{"key":"10.1016\/j.seizure.2015.07.007_bib0215","doi-asserted-by":"crossref","first-page":"46","DOI":"10.18773\/austprescr.2014.020","article-title":"Appropriate use of dose administration aids","volume":"37","author":"Elliott","year":"2014","journal-title":"Aust Prescr"},{"key":"10.1016\/j.seizure.2015.07.007_bib0220","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.yebeh.2008.10.021","article-title":"Prevalence and cost of nonadherence to antiepileptic drugs in elderly patients with epilepsy","volume":"14","author":"Ettinger","year":"2009","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2015.07.007_bib0225","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.yebeh.2012.08.027","article-title":"Adherence to antiepilepsy drug therapy","volume":"25","author":"Faught","year":"2012","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2015.07.007_bib0230","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ijpharm.2011.03.032","article-title":"Variability in commercial carbamazepine samples\u2014impact on drug release","volume":"410","author":"Flicker","year":"2011","journal-title":"Int J Pharm"},{"key":"10.1016\/j.seizure.2015.07.007_bib0235","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1365-2710.2008.00981.x","article-title":"Prochlorperazine tablets repackaged into dose administration aids: can the patient be assured of quality?","volume":"34","author":"Glass","year":"2009","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.seizure.2015.07.007_bib0240","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/j.2055-2335.2006.tb00881.x","article-title":"Stability implications of repackaging paracetamol tablets into dose administration aids","volume":"36","author":"Haywood","year":"2006","journal-title":"J Pharm Pract Res"},{"key":"10.1016\/j.seizure.2015.07.007_bib0245","series-title":"ICH Harmonised Tripartite Guideline. Stability Testing of New Drug Substances and Products Q1A(R2)","author":"ICH","year":"2003"},{"key":"10.1016\/j.seizure.2015.07.007_bib0250","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/j.2055-2335.2013.tb00258.x","article-title":"Stability of paracetamol tablets repackaged in dose administration aids for prn use: implications for practice","volume":"43","author":"Kockler","year":"2013","journal-title":"J Pharm Pract Res"},{"key":"10.1016\/j.seizure.2015.07.007_bib0255","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1093\/eurheartj\/ehq297","article-title":"Strategies to improve drug adherence","volume":"32","author":"Laufs","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.seizure.2015.07.007_bib0260","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1211\/jpp.62.07.0004","article-title":"Stability of sodium valproate tablets repackaged into dose administration aids","volume":"62","author":"Llewelyn","year":"2010","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.seizure.2015.07.007_bib0265","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.yebeh.2008.12.006","article-title":"Association of antiepileptic drug nonadherence with risk of seizures in adults with epilepsy","volume":"14","author":"Manjunath","year":"2009","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2015.07.007_bib0270","series-title":"Martindale: the complete drug reference (electronic resource)","author":"Martindale","year":"2015"},{"key":"10.1016\/j.seizure.2015.07.007_bib0275","series-title":"MedicoPak\u00ae","author":"MedicoPak","year":"2015"},{"key":"10.1016\/j.seizure.2015.07.007_bib0280","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1001\/jama.2011.506","article-title":"Patterns of nonadherence to antiepileptic drug therapy in children with newly diagnosed epilepsy","volume":"305","author":"Modi","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.seizure.2015.07.007_bib0285","series-title":"MPS (Medication Packaging Systems Australia Pty Ltd)","author":"MPS","year":"2015"},{"key":"10.1016\/j.seizure.2015.07.007_bib0290","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/j.2055-2335.2012.tb00171.x","article-title":"Stability of dispersible aspirin tablets repacked into Dosette boxes","volume":"42","author":"Mylrea","year":"2012","journal-title":"J Pharm Pract Res"},{"key":"10.1016\/j.seizure.2015.07.007_bib0295","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.2042-7174.2011.00155.x","article-title":"Clozapine repackaged into Dose Administration Aids: a common practice in Australian hospitals","volume":"20","author":"Perks","year":"2012","journal-title":"Int J Pharm Pract"},{"key":"10.1016\/j.seizure.2015.07.007_bib0300","series-title":"Pharmaceutical Society of Australia, Dose Administration Aids Service","author":"Pharmaceutical Society of Australia","year":"2015"},{"key":"10.1016\/j.seizure.2015.07.007_bib0305","series-title":"Improving patient outcomes through the better use of multi-compartment compliance aids (MCA)","author":"Royal Pharmaceutical Society","year":"2015"},{"key":"10.1016\/j.seizure.2015.07.007_bib0310","series-title":"Nomad\u00ae Monitored Dosage System","author":"Surgichem","year":"2015"},{"key":"10.1016\/j.seizure.2015.07.007_bib0315","series-title":"HealthyPackRX\u00ae by Thrifty White Pharmacy","author":"Thrifty White Pharmacy","year":"2015"},{"key":"10.1016\/j.seizure.2015.07.007_bib0320","series-title":"US Pharmacopeia \u2013 National Formulary (USP 37-NF 32) Online. <701> Disintegration","author":"United States Pharmacopeia","year":"2014"},{"key":"10.1016\/j.seizure.2015.07.007_bib0325","series-title":"US Pharmacopeia \u2013 National Formulary (USP 37-NF 32) Online. <1146> Packaging practice \u2013 Repackaging a single solid oral drug product into a unit-dose container","author":"United States Pharmacopeia","year":"2014"},{"key":"10.1016\/j.seizure.2015.07.007_bib0330","series-title":"Venalink\u00ae","author":"Venalink","year":"2015"},{"key":"10.1016\/j.seizure.2015.07.007_bib0335","series-title":"Webstercare\u00ae","author":"Webstercare","year":"2015"},{"key":"10.1016\/j.seizure.2015.07.007_bib0340","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.clinthera.2011.02.003","article-title":"Does packaging with a calendar feature improve adherence to self-administered medication for long-term use? A systematic review","volume":"33","author":"Zedler","year":"2011","journal-title":"Clin Ther"}],"container-title":["Seizure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131115001788?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131115001788?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T01:46:12Z","timestamp":1761011172000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131115001788"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":34,"alternative-id":["S1059131115001788"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2015.07.007","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Repackaged sodium valproate tablets \u2013 Meeting quality and adherence to ensure seizure control","name":"articletitle","label":"Article Title"},{"value":"Seizure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2015.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}